BIRC5 and neuroblastoma: High expression of survivin has been correlated with poor clinical outcomes in various carcinomas, neuroblastoma (Ito et al. 2005), medulloblastoma (Fangusaro et al. 2005) and also with the chemoresistance in adult rhabdomyosarcoma (RMS) and MPNST (Caldas et al. 2006).